LIR.V - Lamêlée Iron Ore Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
0.475
0.000 (0.00%)
At close: 2:55PM EST
Stock chart is not supported by your current browser
Previous Close0.475
Open0.450
Bid0.470 x 0
Ask0.470 x 0
Day's Range0.450 - 0.475
52 Week Range0.450 - 0.475
Volume13,200
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group3 days ago

    Lamêlee Amends Definitive Agreement for RTO With Aura Health Corp.

    TORONTO , June 21, 2018 /CNW/ - Lamêlee Iron Ore Ltd. (LIR.V) ("LIR" or the "Company") announce that further to its news release dated June 1, 2018 , the Company has amended the terms of the securities exchange agreement dated May 31, 2018 (the "Securities Exchange Agreement") with Aura Health Corp. ("Aura") with respect to the proposed reverse-take-over transaction between the Company and Aura (the "RTO"). The RTO completion deadline has been extended from June 30, 2018 to July 31, 2018 , to allow Aura sufficient time to complete its previously announced private placement of a minimum $1,000,000 and a maximum of $5,000,000 financing (the "Private Placement", together with the RTO, the "Transaction").

  • CNW Group24 days ago

    Lamêlee announces CSE conditional approval and definitive agreement for RTO with Aura Health Corp.

    TORONTO , June 1, 2018 /CNW/ - Lamêlee Iron Ore Ltd. (LIR.V) ("LIR" or the "Company") is pleased to announce that further to its news release dated January 24, 2018 the Company has received conditional approval from the Canadian Securities Exchange (the "CSE") for its listing application and entered into a definitive securities exchange agreement (the "Securities Exchange Agreement") effective May 31, 2018 , pursuant to which the Company will acquire (the "Acquisition") all of the issued and outstanding shares of Aura Health Corp. ("Aura"), from shareholders of Aura (the "Aura Shareholders"). Prior to, or concurrently with, the closing of the Acquisition, Aura will complete a private placement of a minimum $1,000,000 and a maximum of $5,000,000 at a targeted price of $1.00 per Aura security (the "Private Placement" and with the Acquisition, the "Transaction"). Final terms of the Aura Private Placement such as pricing, financing structure, commission and finder's or agent's fees will be subject to final approval by Aura, the CSE and/or other applicable regulatory authorities.

  • Marketwired5 months ago

    Lamelee Announces LOI for RTO with Aura Health Corp.

    Lamelee Iron Ore Ltd. is pleased to announce that it has entered into a letter of intent dated January 23, 2018 with Aura Health Corp. whereby the parties will complete a business combination by way of ...

  • PR Newswire5 months ago

    IIROC Trading Halt - LIR

    VANCOUVER , Jan. 24, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Lamelee Iron Ore Ltd TSX-Venture Symbol: LIR (all issues) Reason: At the Request of the Company Pending News Halt ...

  • CNW Group5 months ago

    IIROC Trading Halt - LIR

    IIROC Trading Halt - LIR

  • What You Must Know About Lamêlée Iron Ore Ltd’s (TSXV:LIR) Risks
    Simply Wall St.9 months ago

    What You Must Know About Lamêlée Iron Ore Ltd’s (TSXV:LIR) Risks

    If you are looking to invest in Lamêlée Iron Ore Ltd’s (TSXV:LIR), or currently own the stock, then you need to understand its beta in order to understand how itRead More...